Larson Financial Group LLC Cue Biopharma, Inc. Transaction History
Larson Financial Group LLC
- $1.92 Billion
- Q4 2024
A detailed history of Larson Financial Group LLC transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Larson Financial Group LLC holds 1,400 shares of CUE stock, worth $1,876. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,400
Previous 1,400
-0.0%
Holding current value
$1,876
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CUE
# of Institutions
57Shares Held
11.9MCall Options Held
22KPut Options Held
1.2K-
Bleichroeder LP New York, NY5MShares$6.7 Million1.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$2.76 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$1.01 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA631KShares$845,9160.0% of portfolio
-
Robertson Stephens Wealth Management, LLC San Francisco, CA479KShares$641,1900.02% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $47.4M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...